Study on the antineoplastic effect of cantharidin and norcantharidin for carcinoma cell of bladder
Haishan Shen,Zhiqiang Song,Shengwen Li,Jianchen Wu,Weidong Zhang,Qiang Li,Shihai Li,Yixin Nie
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.03.022
2015-01-01
Abstract:ObjectiveCantharidin (CA) is recently used as anti-tumor natural medicine in many cancers including bladder carcinoma, but the mechanisms are poorly understood. This study is aimed to explore the inhibit effects of CA and its derivative-norcantharidin (NCTD) on T24, EJ and squamous carcinoma cell (BSCC) of bladderin vitro.Methods Cultured carcinoma cells were treated with CA or NCTD at different concentrations for 12 h, 24 h, 36 h, 48 h and 60 h, then cell viability was measured by MTT assay. After treated by CA and NCTD at optimized concentrations, carcinoma cells cellular morphological changes were also investigated by using Laser Scanning Confocal Microscope (LSCM) and Electron Microscope.Results Human bladder cancer cell proliferation of EJ, T24 and BSCC cells significantly was inhibitedin vitroby CA. EJ and T24 cell proliferation obviously was inhibited by NCTD, and BSCC cell can not be inhibited by NCTD. In a concentration of less than 40 μmol/L, between 12-24 h, the inhibitory effect of CA on proliferation of EJ and T24 cells showed time-effect and dose-effect relationship, drug half inhibitory concentration (IC50) of 24 h is 20 μmol/L. In a concentration of less than 60 μmol/L, between 24-48 h, the inhibition effect of CA on BSCC showed time-effect and dose-effect obvious relationship, IC50 of 48 h was 0 μmol/L. In a concentration of less than 80 μmol/L, between 24-48 h,inhibitory effect of NCTD on proliferation of EJ and T24 cells showed time-effect and dose-effect relationship; IC50 of 24 h was 60 μmol/L. LSCM and electron microscopy confirmed that CA and NCTD inhibited the proliferation of bladder cancer cells through the inducting apoptosis. Both CA and NCTD were able to decrease BSCC viability in time dependent and dose dependent manners; the maximum effect dose was 60 μmol/L. When cells were treated with CA or NCTD at 60 μmol/L for 24 h or 36 h, apoptosis was induced in BSCC, more Apoptotic bodies were founded in CA group.ConclusionCA and NCTD can inhibit the proliferation of common bladder carcinoma cells, is expected to be used in bladder irrigation chemotherapy of superficial bladder tumor after transurethral resection. CA can inhibit the proliferation of BSCC cells, is expected to be used in bladder cancer electrocision specimens with bladder perfusion chemotherapy in patients with BSCC.